Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00XWD
|
||||
Former ID |
DAP001526
|
||||
Drug Name |
Tegaserod
|
||||
Synonyms |
Tegaserod (USAN/INN); 1-[[(Z)-(5-methoxyindol-3-ylidene)methyl]amino]-2-pentylguanidine
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Novartis
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H23N5O
|
||||
InChI |
InChI=1S/C16H23N5O/c1-3-4-5-8-18-16(17)21-20-11-12-10-19-15-7-6-13(22-2)9-14(12)15/h6-7,9-11,20H,3-5,8H2,1-2H3,(H3,17,18,21)/b12-11+
|
||||
InChIKey |
JWXDRFUZDKKGDV-VAWYXSNFSA-N
|
||||
CAS Number |
CAS 189188-57-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
11364906, 11367468, 11370030, 11372869, 11374139, 11378200, 11484916, 11488916, 11491670, 11492545, 11495764, 14776170, 14776171, 26612950, 26749090, 26749091, 34746101, 39384500, 46523984, 47207714, 47662545, 47960011, 48110734, 50107521, 50107522, 53788768, 56464350, 57362102, 78780358, 92124752, 92712636, 93301629, 103276928, 104098381, 114150049, 116933602, 126625387, 126656585, 126667358, 134338707, 134358317, 135018998, 135087697, 135374357, 135651238, 137090514, 137175472, 138069543, 138069544, 138069548
|
||||
ChEBI ID |
ChEBI:51044
|
||||
SuperDrug ATC ID |
A06AX06
|
||||
SuperDrug CAS ID |
cas=145158710
|
||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 4 receptor | Target Info | Agonist | [536224] | |
PathWhiz Pathway | Excitatory Neural Signalling Through 5-HTR 4 and Serotonin | ||||
References | |||||
Ref 536224 | Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313. | ||||
Ref 539432 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 226). | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.